Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G Heijerman

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
The Netherlands Journal of Medicine|August 1, 1993
Quantitative assessment of pancreatic function by magnetic resonance in cystic fibrosisH G Heijerman, R T Tjon a Tham, W Bakker, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1996
Population pharmacokinetics of ceftazidime in cystic fibrosis patients analyzed by using a nonparametric algorithm and optimal sampling strategyA A Vinks, J W Mouton, D J Touw, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 27, 1993
[Continuous intravenous home treatment of airway infections using ceftazidime administration via portable pump in patients with cystic fibrosis; a multicenter study]W Bakker, A A Vinks, J W Mouton, et al.
Therapeutic Drug Monitoring|August 1, 1994
Pharmacokinetics of ceftazidime in adult cystic fibrosis patients during continuous infusion and ambulatory treatment at homeA A Vinks, D J Touw, H G Heijerman, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1997
Pharmacokinetics of aerosolized tobramycin in adult patients with cystic fibrosisD J Touw, F A Jacobs, R W Brimicombe, et al.
International Journal of Pharmaceutics|October 28, 1999
Inhalation of tobramycin in cystic fibrosis. Part 2: optimization of the tobramycin solution for a jet and an ultrasonic nebulizerP P Le Brun, A H de Boer, D Gjaltema, et al.
The European Respiratory Journal|December 6, 2000
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensusG Döring, S P Conway, H G Heijerman, et al.
International Journal of Pharmaceutics|October 28, 1999
Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizerP P Le Brun, A H de Boer, D Gjaltema, et al.
Respiratory Medicine|March 1, 1995
The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosisE H van Haren, J W Lammers, J Festen, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 2, 1994
[Hepatobiliary disorders in cystic fibrosis]P C van de Meeberg, C M Bijleveld, H G Heijerman, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
The Netherlands Journal of Medicine|August 1, 1993
Quantitative assessment of pancreatic function by magnetic resonance in cystic fibrosisH G Heijerman, R T Tjon a Tham, W Bakker, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1996
Population pharmacokinetics of ceftazidime in cystic fibrosis patients analyzed by using a nonparametric algorithm and optimal sampling strategyA A Vinks, J W Mouton, D J Touw, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 27, 1993
[Continuous intravenous home treatment of airway infections using ceftazidime administration via portable pump in patients with cystic fibrosis; a multicenter study]W Bakker, A A Vinks, J W Mouton, et al.
Therapeutic Drug Monitoring|August 1, 1994
Pharmacokinetics of ceftazidime in adult cystic fibrosis patients during continuous infusion and ambulatory treatment at homeA A Vinks, D J Touw, H G Heijerman, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1997
Pharmacokinetics of aerosolized tobramycin in adult patients with cystic fibrosisD J Touw, F A Jacobs, R W Brimicombe, et al.
International Journal of Pharmaceutics|October 28, 1999
Inhalation of tobramycin in cystic fibrosis. Part 2: optimization of the tobramycin solution for a jet and an ultrasonic nebulizerP P Le Brun, A H de Boer, D Gjaltema, et al.
The European Respiratory Journal|December 6, 2000
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensusG Döring, S P Conway, H G Heijerman, et al.
International Journal of Pharmaceutics|October 28, 1999
Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizerP P Le Brun, A H de Boer, D Gjaltema, et al.
Respiratory Medicine|March 1, 1995
The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosisE H van Haren, J W Lammers, J Festen, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 2, 1994
[Hepatobiliary disorders in cystic fibrosis]P C van de Meeberg, C M Bijleveld, H G Heijerman, et al.
Pageof 5